MCB
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fazal, F.
Right arrow Articles by de Lanerolle, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fazal, F.
Right arrow Articles by de Lanerolle, P.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, July 2005, p. 6259-6266, Vol. 25, No. 14
0270-7306/05/$08.00+0     doi:10.1128/MCB.25.14.6259-6266.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Inhibiting Myosin Light Chain Kinase Induces Apoptosis In Vitro and In Vivo

Fabeha Fazal,1 Lianzhi Gu,1 Ivanna Ihnatovych,1 YooJeong Han,1 WenYang Hu,1 Nenad Antic,1 Fernando Carreira,1 James F. Blomquist,2 Thomas J. Hope,2 David S. Ucker,2 and Primal de Lanerolle1*

Departments of Physiology and Biophysics,1 Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, Illinois 606122

Received 6 February 2004/ Returned for modification 19 March 2004/ Accepted 13 April 2005

Previous short-term studies have correlated an increase in the phosphorylation of the 20-kDa light chain of myosin II (MLC20) with blebbing in apoptotic cells. We have found that this increase in MLC20 phosphorylation is rapidly followed by MLC20 dephosphorylation when cells are stimulated with various apoptotic agents. MLC20 dephosphorylation is not a consequence of apoptosis because MLC20 dephosphorylation precedes caspase activation when cells are stimulated with a proapoptotic agent or when myosin light chain kinase (MLCK) is inhibited pharmacologically or by microinjecting an inhibitory antibody to MLCK. Moreover, blocking caspase activation increased cell survival when MLCK is inhibited or when cells are treated with tumor necrosis factor alpha. Depolymerizing actin filaments or detaching cells, processes that destabilize the cytoskeleton, or inhibiting myosin ATPase activity also resulted in MLC20 dephosphorylation and cell death. In vivo experiments showed that inhibiting MLCK increased the number of apoptotic cells and retarded the growth of mammary cancer cells in mice. Thus, MLC20 dephosphorylation occurs during physiological cell death and prolonged MLC20 dephosphorylation can trigger apoptosis.


* Corresponding author. Mailing address: Department of Physiology and Biophysics, University of Illinois at Chicago, 835 South Wolcott Avenue, Chicago, IL 60612. Phone: (312) 996-6430. Fax: (312) 996-1414. E-mail: Primal{at}UIC.edu.


Molecular and Cellular Biology, July 2005, p. 6259-6266, Vol. 25, No. 14
0022-538X/05/$08.00+0     doi:10.1128/MCB.25.14.6259-6266.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2005 by the American Society for Microbiology. All rights reserved.